Immunocore Holdings plc IMCR
- brenetafusp — Cutaneous Melanoma Phase 3
- brenetafusp — Ovarian Cancer Phase 1
PRAME-A02 (1 companies · 2 programs)
Companies with an active program directed at PRAME-A02.
Companies with an active program directed at PRAME-A02.